1.
Impact of Baseline Smoking Status and Body Mass Index in Patients with Hidradenitis Suppurativa Treated with Adalimumab or Placebo in Phase 2 or 3 Studies. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 May 19];1(3.1):s130. Available from: https://skin.dermsquared.com/skin/article/view/74